gene_symbol
ERBB2
hgnc_id
HGNC:3430
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Trastuzumab binds HER2 and opsonizes target cells, engaging Fcγ receptor–bearing effector cells (e.g., NK cells) to mediate ADCC; may also activate complement (CDC).
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Binds extracellular domain (domain IV) of the HER2 receptor
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06000917
disease_id_num_tar_ref
6125
drug_id_num_tar_ref
16606